{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:20:02Z","timestamp":1767676802799,"version":"3.48.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"DOI":"10.1186\/s13098-025-02022-x","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T19:05:49Z","timestamp":1764443149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of changes in diabetes care models and advanced technologies on two-year glycemic control after COVID-19 lockdown in adults with Type 1 Diabetes"],"prefix":"10.1186","volume":"18","author":[{"given":"Lutgarda","family":"Bozzetto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Lupoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Masulli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Creanza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemente","family":"Giglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Macera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Rainone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Annuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brunella","family":"Capaldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"issue":"8","key":"2022_CR1","doi-asserted-by":"publisher","first-page":"e88","DOI":"10.2337\/dc20-1127","volume":"43","author":"B Capaldo","year":"2020","unstructured":"Capaldo B, Annuzzi G, Creanza A, Giglio C, De Angelis R, Lupoli R, et al. Blood glucose control during lockdown for Covid-19: CGM metrics in Italian adults with type 1 diabetes. Diab Care. 2020;43(8):e88-9. https:\/\/doi.org\/10.2337\/dc20-1127.","journal-title":"Diab Care"},{"key":"2022_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109066","volume":"180","author":"M Garofolo","year":"2021","unstructured":"Garofolo M, Aragona M, Rodia C, Falcetta P, Bertolotto A, Campi F, et al. Glycaemic control during the lockdown for COVID-19 in adults with type 1 diabetes: a meta-analysis of observational studies. Diabetes Res Clin Pract. 2021;180:109066.","journal-title":"Diabetes Res Clin Pract"},{"key":"2022_CR3","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2020.0550","author":"\u00d3 Moreno-Dom\u00ednguez","year":"2020","unstructured":"Moreno-Dom\u00ednguez \u00d3, Gonz\u00e1lez-P\u00e9rez de Villar N, Barquiel B, Hillman-Gadea N, Gaspar-Lafuente R, Ar\u00e9valo-G\u00f3mez M, Herranz L. Factors related to improvement of glycemic control among adults with type 1 diabetes during lockdown due to COVID-19. Diabetes Technol Ther. 2020. https:\/\/doi.org\/10.1089\/dia.2020.0550.","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"2022_CR4","doi-asserted-by":"publisher","first-page":"839","DOI":"10.2337\/dc20-2019","volume":"44","author":"L Potier","year":"2021","unstructured":"Potier L, Hansel B, Larger E, Gautier JF, Carreira D, Assemien R, et al. Stay-at-home orders during the COVID-19 pandemic, an opportunity to improve glucose control through behavioral changes in type 1 diabetes. Diabetes Care. 2021;44(3):839\u201343. https:\/\/doi.org\/10.2337\/dc20-2019.","journal-title":"Diabetes Care"},{"key":"2022_CR5","doi-asserted-by":"publisher","first-page":"108682","DOI":"10.1016\/j.diabres.2021.108682","volume":"173","author":"SK Alharthi","year":"2021","unstructured":"Alharthi SK, Alyusuf EY, Alguwaihes AM, Alfadda A, Al-Sofiani ME. The impact of a prolonged lockdown and use of telemedicine on glycemic control in people with type 1 diabetes during the COVID-19 outbreak in Saudi Arabia. Diab Res Clin Pract. 2021;173:108682. https:\/\/doi.org\/10.1016\/j.diabres.2021.108682.","journal-title":"Diab Res Clin Pract"},{"issue":"3","key":"2022_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2022-002789","volume":"10","author":"N Ali","year":"2022","unstructured":"Ali N, El Hamdaoui S, Nefs G, Tack CJ, De Galan BE. Improved glucometrics in people with type 1 diabetes 1 year into the COVID-19 pandemic. BMJ Open Diabetes Res Care. 2022;10(3):e002789. https:\/\/doi.org\/10.1136\/bmjdrc-2022-002789.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2022_CR7","doi-asserted-by":"publisher","first-page":"e4197","DOI":"10.1210\/clinem\/dgac476","volume":"107","author":"T Kaushal","year":"2022","unstructured":"Kaushal T, Tinsley LJ, Volkening LK, Turcotte C, Laffel LM. Improved CGM glucometrics and more visits for pediatric type 1 diabetes using telemedicine during 1 year of COVID-19. J Clin Endocrinol Metab. 2022;107:e4197\u2013202. https:\/\/doi.org\/10.1210\/clinem\/dgac476.","journal-title":"J Clin Endocrinol Metab"},{"key":"2022_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s13300-022-01346-5","volume":"14","author":"H Swaich","year":"2023","unstructured":"Swaich H, Advani A. Sustained improvement in glycemic control in emerging adults with type 1 diabetes 2 years after the start of the COVID-19 pandemic. Diabetes Ther. 2023;14:153\u201365. https:\/\/doi.org\/10.1007\/s13300-022-01346-5.","journal-title":"Diabetes Ther"},{"key":"2022_CR9","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.dsx.2020.07.016","volume":"14","author":"A Verma","year":"2020","unstructured":"Verma A, Rajput R, Verma S, Balania VKB, Jangra B. Impact of lockdown in COVID-19 on glycemic control in patients with type 1 diabetes mellitus. Diabetes Metab Syndr. 2020;14:1213\u20136. https:\/\/doi.org\/10.1016\/j.dsx.2020.07.016.","journal-title":"Diabetes Metab Syndr"},{"issue":"2","key":"2022_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.24911\/SJP.106-1670090324","volume":"23","author":"SA Elrheima","year":"2023","unstructured":"Elrheima SA, Babiker OO. Impact of lockdown during COVID-19 on glycaemic control in children with type 1 diabetes mellitus following at diabetes clinic, Omdurman, Sudan. Sudan J Paediatr. 2023;23(2):163\u201370. https:\/\/doi.org\/10.24911\/SJP.106-1670090324.","journal-title":"Sudan J Paediatr"},{"issue":"6","key":"2022_CR11","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.dsx.2020.08.011","volume":"14","author":"MA Khader","year":"2020","unstructured":"Khader MA, Jabeen T, Namoju R. A cross sectional study reveals severe disruption in glycemic control in people with diabetes during and after lockdown in India. Diab Metab Synd. 2020;14(6):1589\u20131584. https:\/\/doi.org\/10.1016\/j.dsx.2020.08.011.","journal-title":"Diab Metab Synd"},{"issue":"10","key":"2022_CR12","doi-asserted-by":"publisher","first-page":"e1381","DOI":"10.1016\/S2214-109X(22)00361-8","volume":"10","author":"GH Tison","year":"2022","unstructured":"Tison GH, Barrios J, Avram R, Kuhar P, Bostjancic B, Marcus GM, et al. Worldwide physical activity trends since COVID-19 onset. Lancet Glob Health. 2022;10(10):e1381-2. https:\/\/doi.org\/10.1016\/S2214-109X(22)00361-8.","journal-title":"Lancet Glob Health"},{"issue":"11","key":"2022_CR13","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.2337\/dc22-0470","volume":"45","author":"B Matejko","year":"2022","unstructured":"Matejko B, Juza A, Kie\u0107-Wilk B, Cyranka K, Krzy\u017cowska S, Chen X, et al. Transitioning of people with type 1 diabetes from multiple daily injections and self-monitoring of blood glucose directly to minimed 780G advanced hybrid closed-loop system: a two-center, randomized, controlled study. Diabetes Care. 2022;45(11):2628\u201335. https:\/\/doi.org\/10.2337\/dc22-0470.","journal-title":"Diabetes Care"},{"issue":"3","key":"2022_CR14","doi-asserted-by":"publisher","first-page":"628","DOI":"10.2337\/dc22-1971","volume":"46","author":"A Boucsein","year":"2023","unstructured":"Boucsein A, Watson AS, Frewen CM, Sanders OJ, Haszard JJ, Jones SD, et al. Impact of advanced hybrid closed loop on youth with high-risk type 1 diabetes using multiple daily injections. Diabetes Care. 2023;46(3):628\u201332. https:\/\/doi.org\/10.2337\/dc22-1971.","journal-title":"Diabetes Care"},{"issue":"3","key":"2022_CR15","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1177\/19322968231204376","volume":"19","author":"AM G\u00f3mez Medina","year":"2025","unstructured":"G\u00f3mez Medina AM, Henao Carrillo DC, Silva Le\u00f3n JD, G\u00f3mez Gonz\u00e1lez JA, Mu\u00f1oz Velandia OM, Conde Brahim L, et al. Results from a virtual clinic for the follow-up of patients using the advanced hybrid closed-loop system. J Diabetes Sci Technol. 2025;19(3):778\u201386. https:\/\/doi.org\/10.1177\/19322968231204376.","journal-title":"J Diabetes Sci Technol"},{"issue":"1 Suppl 1","key":"2022_CR16","doi-asserted-by":"publisher","first-page":"S146","DOI":"10.2337\/dc25-S007","volume":"48","author":"Diabetes Technology","year":"2025","unstructured":"Diabetes Technology. Standards of care in diabetes-2025. American diabetes association professional practice committee. Diabetes Care. 2025;48(1 Suppl 1):S146\u201366. https:\/\/doi.org\/10.2337\/dc25-S007.","journal-title":"Diabetes Care"},{"key":"2022_CR17","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2337\/dc10-1259","volume":"34","author":"G Charpentier","year":"2011","unstructured":"Charpentier G, Benhamou PY, Dardari D, Clergeot A, Franc S, Schaepelynck-Belicar P, et al. The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study). Diabetes Care. 2011;34:533\u20139. https:\/\/doi.org\/10.2337\/dc10-1259.","journal-title":"Diabetes Care"},{"key":"2022_CR18","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1177\/193229681200600301","volume":"6","author":"DC Klonoff","year":"2012","unstructured":"Klonoff DC. Improved outcomes from diabetes monitoring: the benefits of better adherence, therapy adjustments, patient education, and telemedicine support. J Diabetes Sci Technol. 2012;6:486\u201390. https:\/\/doi.org\/10.1177\/193229681200600301.","journal-title":"J Diabetes Sci Technol"},{"issue":"7","key":"2022_CR19","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1089\/tmj.2018.0128","volume":"25","author":"H Tchero","year":"2019","unstructured":"Tchero H, Kangambega P, Briatte C, Brunet-Houdard S, Retali GR, Rusch E. Clinical effectiveness of telemedicine in diabetes mellitus: a meta-analysis of 42 randomized controlled trials. Telemed J E-Health. 2019;25(7):569\u201383. https:\/\/doi.org\/10.1089\/tmj.2018.0128.","journal-title":"Telemed J E-Health"},{"issue":"5","key":"2022_CR20","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v92i5.11911","volume":"92","author":"P Lazzeroni","year":"2021","unstructured":"Lazzeroni P, Motta M, Monaco S, Laudisio SR, Furoncoli D, Maffini V, et al. Improvement in glycaemic control in paediatric and young adult type 1 diabetes patients during COVID-19 pandemic: role of telemedicine and lifestyle changes. Acta Biomed. 2021;92(5):e2021399. https:\/\/doi.org\/10.23750\/abm.v92i5.11911.","journal-title":"Acta Biomed"},{"key":"2022_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1219661","volume":"11","author":"V De Luca","year":"2023","unstructured":"De Luca V, Bozzetto L, Giglio C, Tramontano G, De Simone G, Luciano A, et al. Clinical outcomes of a digitally supported approach for self-management of type 2 diabetes mellitus. Front Public Health. 2023;11:1219661. https:\/\/doi.org\/10.3389\/fpubh.2023.1219661.","journal-title":"Front Public Health"},{"key":"2022_CR22","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s13300-020-00996-7","volume":"12","author":"F Aberer","year":"2021","unstructured":"Aberer F, Hochfellner DA, Mader JK. Application of telemedicine in diabetes care: the time is now. Diabetes Ther. 2021;12:629\u201339. https:\/\/doi.org\/10.1007\/s13300-020-00996-7.","journal-title":"Diabetes Ther"},{"issue":"1","key":"2022_CR23","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1177\/19322968211050653","volume":"16","author":"L Bozzetto","year":"2022","unstructured":"Bozzetto L, De Angelis R, Calabrese I, Giglio C, Annuzzi G. Clinical outcomes of remote training for advanced diabetes technologies during the COVID-19 pandemic. J Diabetes Sci Technol. 2022;16(1):264\u20135. https:\/\/doi.org\/10.1177\/19322968211050653.","journal-title":"J Diabetes Sci Technol"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-02022-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-025-02022-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-02022-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:10:02Z","timestamp":1767676202000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13098-025-02022-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2022"],"URL":"https:\/\/doi.org\/10.1186\/s13098-025-02022-x","relation":{},"ISSN":["1758-5996"],"issn-type":[{"type":"electronic","value":"1758-5996"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"20 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate\u00a0"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}